| Stage | DDS | % of rev | BURL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $3.0B | 100.00% | BURL ×1.96 |
| Gross profit | $617M | 40.33% | $1.4B | 46.24% | BURL +5.9pp |
| Operating income | $129M | 8.45% | $251M | 8.38% | DDS +0.1pp |
| Pre-tax income | $127M | 8.31% | $242M | 8.06% | DDS +0.2pp |
| Net income | $98M | 6.38% | $184M | 6.14% | DDS +0.2pp |
| Stage | DDS | BURL | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $3.0B100.00% | BURL ×1.96 |
| Gross profit | 40.33%$617M | 46.24%$1.4B | BURL +5.9pp |
| Operating income | 8.45%$129M | 8.38%$251M | DDS +0.1pp |
| Pre-tax income | 8.31%$127M | 8.06%$242M | DDS +0.2pp |
| Net income |
| 6.38%$98M |
| 6.14%$184M |
| DDS +0.2pp |
No shared counterparties.